Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?

To: Jacques Tootight who wrote (696)	4/15/1998 1:25:00 PM
From: Bryce Elkins	Respond to of 1580

RC - Can you post the date and source? TIA Ble

To: Jacques Tootight who wrote (696)	4/15/1998 3:14:00 PM
From: Rob L.	Read Replies (3) \| Respond to of 1580

Judging by the movement of the stock it does not look like the earnings will be very good. While not jumping to conclusions just yet, management should have pre-warned if there was going to be a problem. The stock is off almost $4 today and is down almost 9% in the last week or so. The stock had no reaction to FDA approval of its new drug. However, MRK does tend to have exaggerated movements both on the upside and the downside. As I am a long-term holder (holding since 29 from a few years back), I have no intention of bailing out just yet. The future is too bright for this and the other drug companies. Medco is very profitable and has been aiding earnings for some time. I expect this to continue. We will see. Regards